Share this content in WeChat
Original Article
Experimental study of Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging quantitative assessment of moderate liver fibrosis value in rats
GE Yansong  SHI mingqi  SUN linna  WANG Peiyuan 

Cite this article as: Ge YS, Shi MQ, Sun LN, et al. Experimental study of Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging quantitative assessment of moderate liver fibrosis value in rats[J]. Chin J Magn Reson Imaging, 2022, 13(1): 91-97. DOI:10.12015/issn.1674-8034.2022.01.018.

[Abstract] Objective To investigate the value of ethoxybenzyl diethylene-triamine-pentaacetic-acid (Gd-EOB-DTPA)-dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to quantify the value of moderate hepatic fibrosis (HF) in rats.Materials and Methods: A total of 40 male Wistar rats (10 in the control group and 30 in the experimental group) were intraperitoneally injected with CCl4 to construct HF models of different stages, and axial T1WI and DCE-MRI scans of liver were performed to obtain the following parameters: Volume transport constant (Ktrans), rate constant (Kep), percentage of extracellular space volume (Ve), and initial area under curve (iAUC). All rats were blooded intravenously to determine the content of hyaluronic acid (HA) and layer adhesive protein (LN) in the serum. The liver tissue of rats was taken for HF pathology stage. The difference between DCE-MRI parameters and serological indicators in normal group, normal group and mild HF group and moderate HF group was compared with independent sample t-test; the difference between DCE-MRI parameters and serological index in different HF stages was compared by using the single-factor variance analysis, the correlation between DCE-MRI parameter and serological indicators and HF stage were analyzed by using the Spearman correlation test;the value of moderate HF for diagnosis of each parameter is compared by using the ROC curve.Results A total of 26 rats were included in the study, of which 6 were pathologically staged for normal group, 7 were mild HF (F1) and 13 were moderate HF (F2—F3), all of DCE-MRI parameters (Ktrans, Ve, Kep and iAUC) decreased with HF (r=-0.665, P<0.001; r=-0.395, P=0.046; r=-0.565, P=0.003; r=-0.538, P=0.005), serum LN and HA content increased with HF (r=0.606, P=0.001; r=0.601, P=0.001); Ktrans, Ve and iAUC had statistical differences between the experimental group and the normal group, the normal group and the mild HF group and the moderate HF group, the normal group and the moderate HF group, the mild HF and the moderate HF group (P<0.05); the differences in serum LN and HA content between the control group and the moderate HF group were statistically significant (P<0.05); and the ROC curve shows that Ktrans and LN diagnose moderate HF with the highest efficiency.Conclusions Gd-EOB-DTPA DCE-MRI quantitative evaluation has good diagnostic value for moderate HF staged, of which Krans has the best diagnostic efficiency in DCE-MRI parameters.
[Keywords] hepatic fibrosis;gadolinium ethoxybenzyl diethylene-triamine-pentaacetic-acid;dynamic contrast-enhanced magnetic resonance imaging;capacity transfer constant

GE Yansong   SHI mingqi   SUN linna   WANG Peiyuan*  

Department of Medical Radiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China

Wang PY, E-mail:

Conflicts of interest   None.

ACKNOWLEDGMENTS Natural Science Foundation of Shandong Province (No. ZR2018MH034).
Received  2021-10-08
Accepted  2021-11-25
DOI: 10.12015/issn.1674-8034.2022.01.018
Cite this article as: Ge YS, Shi MQ, Sun LN, et al. Experimental study of Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging quantitative assessment of moderate liver fibrosis value in rats[J]. Chin J Magn Reson Imaging, 2022, 13(1): 91-97. DOI:10.12015/issn.1674-8034.2022.01.018.

Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues[J]. Mol Aspects Med, 2019, 65: 37-55. DOI: 10.1016/j.mam.2018.09.002.
Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update[J]. Hepatology, 2009, 49(4): 1335-74. DOI: 10.1002/hep.22759.
Ronot M, Asselah T, Paradis V, et al. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT[J]. Radiology, 2010, 256(1): 135-42. DOI: 10.1148/radiol.10091295.
Hu XR, Cui XN, Hu QT, et al. Value of MR diffusion imaging in hepatic fibrosis and its correlations with serum indices[J]. World J Gastroenterol, 2014, 20(24): 7964-70. DOI: 10.3748/wjg.v20.i24.7964.
Lai M, Afdhal NH. Liver Fibrosis Determination[J]. Gastroenterol Clin North Am, 2019, 48(2): 281-289. DOI: 10.1016/j.gtc.2019.02.002.
Liu HF, Wang Q, Du YN, et al. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits[J]. Magn Reson Imaging, 2020, 70: 57-63. DOI: 10.1016/j.mri.2020.04.010.
Liu C, Sun R, Wang J, et al. Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma[J]. Biomed Res Int, 2020: 2576563. DOI: 10.1155/2020/2576563.
Tanaka T, Nishida H, Mie K, et al. Assessment of hepatitis and fibrosis using Gd-EOB-DTPA MRI in dogs[J]. Vet Rec Open, 2020, 7(1): e000371. DOI: 10.1136/vetreco-2019-000371.
Verloh N, Utpatel K, Haimerl M, et al. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study[J]. Sci Rep, 2018, 8(1): 6207. DOI: 10.1038/s41598-018-24316-z.
Verloh N, Utpatel K, Haimerl M, et al. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation[J]. Sci Rep, 2015, 5: 15408. DOI: 10.1038/srep15408.
Li XQ, Wang X, Zhao DW, et al. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma[J]. World J Surg Oncol,2020, 18(1): 219. DOI: 10.1186/s12957-020-01996-4.
Xu J, Wang X, You Y, et al. Gadolinium Ethoxybenzyl Diethylene-triamine-pentaacetic-acid-enhanced Magnetic Resonance Imaging Perfusion and Multiple Hepatobiliary-phase Imaging for Quantitative Assessment of Liver Fibrosis in Rat Models[J]. Acta Academiae Medicinae Sinicae, 2018, 40(6): 809-816. DOI: 10.3881/j.issn.1000-503X.11033.
Miao YY, Yu SN, Li XF, et al. Value of incoherent movement within magnetic resonance voxels and diffusion kurtosis imaging in the diagnosis of liver fibrosis[J]. Chin J Gerontol, 2017, 37(3): 681-682,683. DOI: 10.3969/j.issn.1005-9202.2017.03.070.
Lu HJ, Zhan YF, Li Q, et al. Experimental study of apparent diffusion coefficient from 3.0 T MRI in identification of moderate liver fibrosis[J]. China J Modern Med, 2017, 27(19): 17-21. DOI: 10.3969/j.issn.1005-8982.2017.19.004.
Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives[J]. Cells, 2020, 9(4). DOI: 10.3390/cells9040875.
Aydın MM, Akçalı KC. Liver fibrosis[J]. Turk J Gastroenterol, 2018, 29(1): 14-21. DOI: 10.5152/tjg.2018.17330.
Lu LG. Highlight in hepatic fibrosis[J]. J of Pract Hepat, 2016, (1): 1-3. DOI: 10.3969/j.issn.1672-5069.2016.01.001.
Zhang W, Kong X, Wang ZJ, et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats[J]. PLoS One, 2015, 10(6): e0129621. DOI: 10.1371/journal.pone.0129621.
Guo QL, Huang YJ, Chen ZX, et al. The formation of sinusoidal capillarization in the process of liver fibrosis induced by carbon tetrachloride in rats[J]. Chin Hepat, 2014, (11): 839-843. DOI: 10.3969/j.issn.1008-1704.2014.11.009.
Huang YH, Guo YM, Xu HG, et al. Comparative study of time-intensity curve and Ktrans value of dynamic contrast-enhanced MRI in the diagnosis of prostate cancer[J]. Radiol Pract, 2016, 31(6): 511-515. DOI: 10.13609/j.cnki.1000-0313.2016.06.008.
Li Z, Sun J, Chen L, et al. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging[J]. J Magn Reson Imaging, 2016, 44(1): 98-104. DOI: 10.1002/jmri.25132.
Zhang LP, Wu XL, Huang BS, et al. A Study of Gd-EOB-DTPA Dynamic Contrast Enhanced MRI in Quantitatively Assessing Liver Fibrosis in Rabbits[J]. Hebei Med, 2020, 26(8): 1333-1338. DOI: 10.3969/j.issn.1006-6233.2020.08.024.
Jiang JZ, Zhou LQ, Zhang H, et al. Quantitative experimental study in a rabbit model of liver fibrosis by DCE-MRI with Gd-EOB-DTPA[J]. Chin J Magn Reson Imaging, 2021, 12(6): 66-71. DOI: 10.12015/issn.1674-8034.2021.06.013.
Younesi S, Parsian H. Diagnostic accuracy of glycoproteins in the assessment of liver fibrosis: A comparison between laminin, fibronectin, and hyaluronic acid[J]. Turk J Gastroenterol, 2019, 30(6): 524-531. DOI: 10.5152/tjg.2019.17339.
Yang YM, Noureddin M, Liu C, et al. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis[J]. Sci Transl Med, 2019, 11(496):eaat9284. DOI: 10.1126/scitranslmed.aat9284.
Liu Y, Guo CL.Clinical study of Bicyclol treatment in chronic viral hepatitis B[J]. J Clin Hepat, 2004, 20(2): 91-92. DOI: 10.3969/j.issn.1001-5256.2004.02.012.

PREV The correlation between brain gray matter volume changes and executive function in patients with end-stage renal disease
NEXT The effect of bandwidth on evaluation of T1, T2 relaxation times and proton density using synthetic MRI: A phantom study

Tel & Fax: +8610-67113815    E-mail: